Author

Flori Sassano

Observed names: F Sassano, F. Sassano

Institution: University of Kansas Medical Center

Observed institutions: University of North Carolina at Chapel Hill, Emory University, Fudan University, University of Kansas Medical Center, Children's Healthcare of Atlanta, University of Missouri

OpenAlex ID: A5052253265

Loose ENDs: Electronic Nicotine Delivery Systems and the FDA’s Recent Enforcement Policy

2020 · Saira Ahmad, Flori Sassano, et al. · EMJ Respiratory · 3

D29-13 Eld607 Attenuates Pulmonary Fibrosis By Suppressing Orai1-mediated Ca²+ Signaling

2026 · P K Anand, F Sassano, et al. · American Journal of Respiratory and Critical Care Medicine

369 Peripheral blood neutrophil dysfunction persists in people with CF taking elexacaftor/tezacaftor/ivacaftor

2025 · J. Wrennall, M. Biggart, et al. · Journal of Cystic Fibrosis

211 AVP10 is a novel anti-viral peptide with reduced activity in the CF airway

2025 · M. Biggart, F. Sassano, et al. · Journal of Cystic Fibrosis

Use of non-invasive wearables biomonitoring to detect presmoking, smoking and postsmoking stages: protocol for an observational laboratory study

2025 · Sherine El-Toukhy, Shahab Haghayegh, et al. · BMJ Open

The Orai1 Antagonist, ELD607, Reduces Chronic Neutrophilic Inflammation in βENaC Mice

2024 · S. Ahmad, M. Biggart, et al.

The Orai1 Antagonist ELD607 Safely Reduces Lung Inflammation in G551D Cystic Fibrosis Ferrets

2024 · F. Sassano, S. Ahmad, et al.

21 ELD403 demonstrates anti-viral activity by aggregating respiratory syncytial virus and reducing the free viral load

2023 · M. Biggart, F. Sassano, et al. · Journal of Cystic Fibrosis

171 Abnormal calcium signaling in cystic fibrosis neutrophils is inversely correlated with FEV1 and can be corrected with the Orai1 antagonist ELD607

2023 · J. Wrennall, A. Ghosh, et al. · Journal of Cystic Fibrosis

3 ELD607, a novel Orai1 antagonist, reduces inflammation and clears Burkholderia cepacia complex and multidrug-resistant Pseudomonas aeruginosa from the lungs

2023 · S. Ahmad, F. Sassano, et al. · Journal of Cystic Fibrosis

ELD403 as a Novel Anti-viral Therapy for RSV-related Infections in Cystic Fibrosis

2023 · R. Tarran, F. Sassano, et al.

383 ELD607 inhibits excessive proinflammatory Ca2+ signaling in cystic fibrosis neutrophils

2022 · J. Wrennall, A. Ghosh, et al. · Journal of Cystic Fibrosis

Works count: 12

Citation count: 3

H-index: 1

I10-index: